Cytosorbents Cor (CTSO)

$1.03 -0.01 (-0.96%)
Market Cap 56.32M
Revenue (ttm) 36.35M
Net Income (ttm) -28.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -78.43%
Debt to Equity Ratio 1.06
Volume 56,800
Avg Vol 310,488
Day's Range N/A - N/A
Shares Out 54.68M
Stochastic %K 49%
Beta 0.58
Analysts Strong Sell
Price Target $5.00

Latest News on CTSO

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

Jan 3, 2025, 7:00 AM EST - 16 days ago

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

Dec 12, 2024, 7:00 AM EST - 5 weeks ago

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

Nov 11, 2024, 7:30 AM EST - 2 months ago

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 1:20 PM EST - 2 months ago

Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

Oct 1, 2024, 7:00 AM EDT - 3 months ago

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

Aug 27, 2024, 7:00 AM EDT - 5 months ago

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 16, 2024, 4:05 PM EDT - 5 months ago

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 10:31 PM EDT - 5 months ago

Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

Aug 13, 2024, 4:19 PM EDT - 5 months ago

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

Aug 13, 2024, 4:18 PM EDT - 5 months ago

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

Aug 7, 2024, 7:00 AM EDT - 5 months ago

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

Aug 1, 2024, 7:00 AM EDT - 6 months ago

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

Jul 30, 2024, 2:00 AM EDT - 6 months ago

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

Jul 17, 2024, 7:00 AM EDT - 6 months ago

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

CytoSorbents Secures $20 Million Credit Facility

Jul 2, 2024, 7:00 AM EDT - 7 months ago

CytoSorbents Secures $20 Million Credit Facility

CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

Jun 5, 2024, 7:00 AM EDT - 8 months ago

CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript

May 9, 2024, 11:01 PM EDT - 9 months ago

Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript

CytoSorbents Reports First Quarter 2024 Results

May 9, 2024, 4:17 PM EDT - 9 months ago

CytoSorbents Reports First Quarter 2024 Results

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

Apr 26, 2024, 7:00 AM EDT - 9 months ago

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

Apr 17, 2024, 7:00 AM EDT - 9 months ago

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 10:24 PM EDT - 11 months ago

CytoSorbents Corporation (CTSO) Q4 2023 Earnings Call Transcript

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

Mar 14, 2024, 4:39 PM EDT - 11 months ago

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

Mar 6, 2024, 7:00 AM EST - 11 months ago

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

Feb 8, 2024, 7:00 AM EST - 1 year ago

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

Jan 17, 2024, 7:15 AM EST - 1 year ago

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

Dec 28, 2023, 7:00 AM EST - 1 year ago

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

Dec 13, 2023, 9:15 AM EST - 1 year ago

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

Cytosorbents Corporation (CTSO) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 10:06 PM EST - 1 year ago

Cytosorbents Corporation (CTSO) Q3 2023 Earnings Call Transcript

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

Nov 9, 2023, 4:15 PM EST - 1 year ago

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

Oct 27, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

CytoSorbents to Present at the 8th Annual Dawson James Conference

Oct 5, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents to Present at the 8th Annual Dawson James Conference

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

Sep 27, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

Sep 19, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation

Sep 11, 2023, 11:32 AM EDT - 1 year ago

CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation

CytoSorbents Announces Resignation of Chief Financial Officer Alexander D'Amico

Sep 1, 2023, 4:43 PM EDT - 1 year ago

CytoSorbents Announces Resignation of Chief Financial Officer Alexander D'Amico

CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil

Aug 31, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil

CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial

Aug 14, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial

Cytosorbents Corporation (CTSO) Q2 2023 Results Earnings Conference Call

Aug 1, 2023, 9:25 PM EDT - 1 year ago

Cytosorbents Corporation (CTSO) Q2 2023 Results Earnings Conference Call

CytoSorbents Reports Second Quarter 2023 Financial and Operational Results

Aug 1, 2023, 4:15 PM EDT - 1 year ago

CytoSorbents Reports Second Quarter 2023 Financial and Operational Results

CytoSorbents to Report Second Quarter 2023 Operating and Financial Results

Jul 26, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents to Report Second Quarter 2023 Operating and Financial Results

CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer

Jul 19, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial

Jul 7, 2023, 7:07 AM EDT - 1 year ago

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial

Cytosorbents Corporation (CTSO) Q1 2023 Earnings Call Transcript

May 2, 2023, 10:11 PM EDT - 1 year ago

Cytosorbents Corporation (CTSO) Q1 2023 Earnings Call Transcript

CytoSorbents Reports First Quarter 2023 Results

May 2, 2023, 4:15 PM EDT - 1 year ago

CytoSorbents Reports First Quarter 2023 Results

CytoSorbents to Report First Quarter 2023 Operating and Financial Results

Apr 26, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents to Report First Quarter 2023 Operating and Financial Results

CytoSorbents Announces Board Chairman Al W. Kraus To Retire

Apr 19, 2023, 7:00 AM EDT - 1 year ago

CytoSorbents Announces Board Chairman Al W. Kraus To Retire

Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation

Mar 29, 2023, 8:30 AM EDT - 1 year ago

Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation

CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

Mar 22, 2023, 8:09 AM EDT - 1 year ago

CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

CytoSorbents Comments on Bank Exposure and Diversified Cash Position

Mar 14, 2023, 7:00 AM EDT - 2 years ago

CytoSorbents Comments on Bank Exposure and Diversified Cash Position